As an intensive care unit (ICU) nurse caring for a 230‑lb patient with hypotension, how should I administer vasopressin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasopressin Administration for Hypotension in ICU

Vasopressin should NOT be used as your first-line vasopressor—start norepinephrine first, then add vasopressin at 0.03 units/minute (fixed dose, not weight-based) if your patient remains hypotensive despite adequate norepinephrine. 1

Initial Vasopressor Choice

Your patient needs norepinephrine as the first-choice vasopressor for hypotension 1. The Surviving Sepsis Campaign guidelines provide strong recommendations (moderate quality evidence) that norepinephrine is the initial agent for vasodilatory shock. Vasopressin is explicitly not recommended as a single initial vasopressor for sepsis-induced hypotension 1.

When to Add Vasopressin

Add vasopressin when:

  • Your patient remains hypotensive despite adequate fluid resuscitation AND
  • Norepinephrine is already running (typically when doses reach 0.25-0.50 mcg/kg/min, though some evidence suggests considering it earlier) 1, 2

The intent is either to raise MAP to target OR to decrease the norepinephrine dose 1.

How to Prepare and Administer Vasopressin

Preparation

  1. Dilute the 20 units/mL vial in either normal saline (0.9% NaCl) or D5W 3
  2. Common dilution concentrations: 0.1 units/mL or 1 unit/mL 3
  3. Discard unused diluted solution after 18 hours at room temperature or 24 hours refrigerated 3

Dosing (Weight-Independent)

  • Starting dose for septic shock: 0.01 units/minute 3
  • Target dose: 0.03 units/minute (this is the standard add-on dose) 1, 3
  • Titrate up by 0.005 units/minute at 10-15 minute intervals if needed 3
  • Maximum recommended dose: 0.03-0.04 units/minute for routine use 1
  • Doses above 0.04 units/minute should be reserved for salvage therapy only 1

Critical point: Your patient's weight (230 lbs/104 kg) does NOT affect vasopressin dosing—it's a fixed-dose medication, unlike norepinephrine 3.

Target Blood Pressure

  • Initial MAP target: 65 mm Hg 1
  • Titrate vasopressors to achieve this target
  • Place an arterial line as soon as practical for accurate monitoring 1

Weaning Strategy

Once target blood pressure is maintained for 8 hours without catecholamines:

  • Taper vasopressin by 0.005 units/minute every hour as tolerated 3
  • Recent evidence shows no significant difference in rebound hypotension whether you discontinue vasopressin or norepinephrine first 4
  • However, if vasopressin has been running >24 hours, rebound hypotension risk is lower (9% incidence overall) 2

Important Caveats

Adverse effects to monitor:

  • Decreased cardiac output and bradycardia 3
  • Coronary, mesenteric, skin, or digital ischemia 3
  • Hyponatremia 3
  • At high doses (>0.03-0.04 units/min), vasopressin markedly impairs splanchnic perfusion 5

Contraindications:

  • Known allergy to vasopressin or chlorobutanol 3

Special considerations:

  • Obesity and hyperlactatemia are negatively associated with vasopressin responsiveness 2
  • Higher norepinephrine doses (≥0.30 mcg/kg/min) predict better vasopressin response 2
  • New-onset atrial fibrillation occurs less frequently in vasopressin responders 2

Common Pitfall

Do not use vasopressin alone as your initial vasopressor. This is a frequent error—vasopressin must be added to norepinephrine, not used instead of it 1. The guidelines are explicit that low-dose vasopressin should not be the single initial vasopressor for sepsis-induced hypotension.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.